ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’ (@makimaki787) 's Twitter Profile
ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’

@makimaki787

ใƒœใƒฉใƒ—ใ‹ใ‚‰Queenใซใƒใƒžใฃใกใ‚ƒใฃใŸใƒžใƒณ/ๆœ€่ฟ‘ใฏๆ—ฅๅธธ็š„ใชใƒ„ใ‚คใƒผใƒˆใฏใปใจใ‚“ใฉใ—ใฆใ„ใชใ„ๅžข/ๅŸบๆœฌ็ฎฑๆŽจใ—ใฎใƒ™ใƒผใ‚นใจใ‚ฎใ‚ฟใƒผใฎๅญใณใ„ใใฎไบบใ€‚็ตตใฏใปใผIGใซ่ผ‰ใ›ใฆใพใ™ใ€‚QAL2024.ๅๅคๅฑ‹ใ€ๆœญๅนŒใ€ๆฑไบฌ2ๆ—ฅ็›ฎๅ‚ๆˆฆใ—ใพใ—ใŸใ€‚

ID: 1162744465682923521

linkhttps://www.instagram.com/makimaki_pika calendar_today17-08-2019 15:14:38

89,89K Tweet

1,1K Followers

1,1K Following

ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’ (@makimaki787) 's Twitter Profile Photo

$NXL NXL's device has received FDA approval for the treatment of anxiety, depression, and insomnia, and plans to expand its application to Alzheimer's disease and dementia; recent clinical progress may boost the stock price.

$NXL
NXL's device has received FDA approval for the treatment of anxiety, depression, and insomnia, and plans to expand its application to Alzheimer's disease and dementia; recent clinical progress may boost the stock price.
ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’ (@makimaki787) 's Twitter Profile Photo

$OPTX Winning a new ballistic optics contract with the US military and joining industry leaders in providing AI-driven augmented reality (AR) systems. The January 20th AGM will discuss the 2026 strategy, which could potentially boost the stock price.

$OPTX 
Winning a new ballistic optics contract with the US military and joining industry leaders in providing AI-driven augmented reality (AR) systems. The January 20th AGM will discuss the 2026 strategy, which could potentially boost the stock price.
ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’ (@makimaki787) 's Twitter Profile Photo

$RNAZ Target Price: $10.00 TX-MC138 effectively targets glioblastoma, supporting its future clinical development. With the increasing popularity of nucleoside (nucleotide) analog (NA) therapies, the inhibitory effect of RNAZ on miR-10b is expected to attract widespread attention.

$RNAZ
Target Price: $10.00
TX-MC138 effectively targets glioblastoma, supporting its future clinical development. With the increasing popularity of nucleoside (nucleotide) analog (NA) therapies, the inhibitory effect of RNAZ on miR-10b is expected to attract widespread attention.
ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’ (@makimaki787) 's Twitter Profile Photo

$IBIO Target Price: $2.90 The potential of the IBIO-610 antibody, which promises to bring innovation to the fields of obesity and cardiovascular metabolic diseases, has attracted numerous investors to this rating report, highlighting the uniqueness of its product pipeline.

$IBIO
Target Price: $2.90
The potential of the IBIO-610 antibody, which promises to bring innovation to the fields of obesity and cardiovascular metabolic diseases, has attracted numerous investors to this rating report, highlighting the uniqueness of its product pipeline.
ใƒžใ‚ญใƒใ€‚๐ŸŒท๐Ÿ๐ŸŒท๐Ÿฅบโœจ๐ŸŽ’ (@makimaki787) 's Twitter Profile Photo

$LAB Target Price: $1.90 A life science tools company that provides genomics and proteomics tools, including flow cytometry and mass cytometer systems, for biological research and diagnostics.

$LAB 
Target Price: $1.90 
A life science tools company that provides genomics and proteomics tools, including flow cytometry and mass cytometer systems, for biological research and diagnostics.
Heisenberg (@mr_derivatives) 's Twitter Profile Photo

$HOOD I miss the days when you open up your Robinhood app and you see that oh so sweet 5.00% APY on your cash. Now itโ€™s only 3.75%โ€ฆ ๐Ÿ˜ญ A 5% whole number justโ€ฆjustโ€ฆ looks cooler. Raise em rates Jay Pow Wow lol

Shay Boloor (@stocksavvyshay) 's Twitter Profile Photo

$NVDA 10 years ago: โ€ข $1/share โ€ข 10x earnings $NVDA today: โ€ข $185/share โ€ข 26x earnings That means the stock is up ~18,400% while valuation multiple has barely more than doubled. Thatโ€™s what happens when you own the infrastructure every new digital economy has to run on.

$NVDA 10 years ago:
โ€ข $1/share
โ€ข 10x earnings

$NVDA today:
โ€ข $185/share
โ€ข 26x earnings

That means the stock is up ~18,400% while valuation multiple has barely more than doubled. 

Thatโ€™s what happens when you own the infrastructure every new digital economy has to run on.
Mike Investing (@mrmikeinvesting) 's Twitter Profile Photo

A portfolio involving these 10 picks will dominate & outperform the markets by a far margin in 2026โ€ฆ 1. $ONDS ~ Provides the secure & jam-resistant communication for autonomous drone operations. 2. $ASTS ~ Building the communication layer for space based connectivity. 3. $ZETA

A portfolio involving these 10 picks will dominate & outperform the markets by a far margin in 2026โ€ฆ

1. $ONDS ~ Provides the secure & jam-resistant communication for autonomous drone operations.
2. $ASTS ~ Building the communication layer for space based connectivity.
3. $ZETA
Mike Investing (@mrmikeinvesting) 's Twitter Profile Photo

$BABA is going to see its largest breakout in its history over the next couple monthsโ€ฆ With a massive revenue and stock price disconnect $BABA will catch back up soon. The last time I called for a move like this $BABA ran from $90 to $180+ Save this post to look back onโ€ฆ

$BABA is going to see its largest breakout in its history over the next couple monthsโ€ฆ

With a massive revenue and stock price disconnect $BABA will catch back up soon.

The last time I called for a move like this $BABA ran from $90 to $180+

Save this post to look back onโ€ฆ
Shay Boloor (@stocksavvyshay) 's Twitter Profile Photo

$RIOT bought 200 acres in Rockdale for $96M using proceeds from ~1,080 $BTC sold and signed a 25MW data center lease with $AMD. The 10-year deal is valued at ~$311M with extensions up to ~$1B plus options for AMD to add 75MW and a right of first refusal on another 100MW.

$RIOT bought 200 acres in Rockdale for $96M using proceeds from ~1,080 $BTC sold and signed a 25MW data center lease with $AMD.

The 10-year deal is valued at ~$311M with extensions up to ~$1B plus options for AMD to add 75MW and a right of first refusal on another 100MW.
Shay Boloor (@stocksavvyshay) 's Twitter Profile Photo

10 STOCKS UNDER $2B MARKET CAP WORTH TRACKING 1. $CLPT | ClearPoint Neuro 2. $AEHR | Aehr Test System 3. $JMIA | Jumia 4. $OSS | One Stop Systems 5. $PRCT | PROCEPT BioRobotics 6. $PGY | Pagaya 7. $PRME | Prime Medicine 8. $KRKNF | Kraken Robotics 9. $RR | Richtech Robotics